Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome
A legfontosabb adatok
- Ki végzi
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Hol
- Beijing (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 120 fő, tervezett
- Kezdés
- 2027. jan. 1.
- Várható befejezés
- 2028. dec. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- Hewei Anchang Formula Granules
- Hewei Anchang Formula Matching Placebo Granules
- A regiszteradat frissítve
- 2026. július 20.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults who have both functional dyspepsia (ongoing indigestion with no visible cause) and irritable bowel syndrome with diarrhea. It tests a Chinese herbal granule against a placebo.
- Életkor
- 18 to 65 years
- Nem
- All sexes can join.
- A betegség stádiuma
- Both conditions must be diagnosed by the Rome IV criteria. People must also have the traditional Chinese medicine patterns named in the record: liver-stomach disharmony for the indigestion, and liver qi stagnation with spleen deficiency for the bowel syndrome.
- Korábbi kezelés
- People cannot join if they now use, or plan to keep using, medicines that affect the gut. These include gut-motility drugs, antidiarrheal drugs, antidepressants, anxiety drugs, gut bacteria products and antibiotics.
A részvétel fő kizáró okai
- Severe heart, liver, kidney, blood or lung disease, or cancer
- Other gut diseases such as peptic ulcer or ulcerative colitis, or diseases such as hyperthyroidism or diabetes
- Severe anxiety or depression, with a HADS score of ≥15 on either part
- Pregnant, breastfeeding or planning pregnancy
- Taking part in another drug trial now or within the previous 4 weeks
A regiszter feltételei, szó szerint
Mind a 13 feltétel megnézéseKevesebb
Ki vehet részt
- Meet the Rome IV diagnostic criteria for both functional dyspepsia (FD) and diarrhea-predominant irritable bowel syndrome (IBS-D)
- Meet the diagnostic criteria for liver-stomach disharmony syndrome in FD and liver qi stagnation with spleen deficiency syndrome in IBS-D
- Aged 18-65 years, with no restriction on sex
- Fully informed about the study and voluntarily provide written informed consent. -
Ki nem vehet részt
- Current or anticipated continuous use of medications that may affect gastrointestinal function, including prokinetic agents, antidiarrheal agents, antidepressants, anxiolytics, gut microbiota-modulating agents, and antibiotics
- Current participation in another drug clinical trial or participation in another drug clinical trial within the previous 4 weeks
- Severe primary diseases of the cardiovascular, hepatic, renal, hematologic, or respiratory systems, or malignant tumors
- Other organic gastrointestinal diseases, such as peptic ulcer or ulcerative colitis, or systemic diseases that may affect gastrointestinal motility, such as hyperthyroidism or diabetes mellitus
- A history of allergy to any study-related medication or a history of severe food allergy
- Psychiatric disorders, intellectual impairment, or language impairment
- A suspected or confirmed history of alcohol or drug abuse, or other circumstances that, in the investigator's judgment, may reduce the likelihood of enrollment or complicate study participation, such as frequent changes in the work environment that may increase the risk of loss to follow-up. -
- Women who are planning pregnancy, pregnant, or breastfeeding
- Severe anxiety or depression, as assessed using the Hospital Anxiety and Depression Scale (HADS). An anxiety subscale score of ≥15 is defined as severe anxiety, and a depression subscale score of ≥15 is defined as severe depression. Participants meeting the criterion for severe anxiety or severe depression on either subscale will be excluded
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 65 év között vagy?
Helyszínek itt: Kína
- Xiyuan Hospital of China Academy of Chinese Medical SciencesBeijing, KínaContact: Lin LvToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
1. To conduct a multicenter, randomized controlled trial across four hospitals to evaluate the efficacy of Hewei Anchang Formula in patients with overlapping gastrointestinal symptoms of functional dyspepsia (FD) and diarrhea-predominant irritable bowel syndrome (IBS-D), characterized by liver-stomach disharmony syndrome and liver stagnation-spleen deficiency syndrome, respectively. By leveraging the holistic regulatory effects of Chinese herbal formulas and the traditional Chinese medicine principle of "treating different diseases with the same therapeutic approach," this study aims to generate high-level evidence for the management of overlapping gastrointestinal symptoms in functional gastrointestinal disorders (FGIDs) and to establish a standardized and scalable therapeutic strategy. 2. To elucidate the potential mechanisms underlying the therapeutic effects of Hewei Anchang Formula on overlapping gastrointestinal symptoms of FD and IBS-D through multiple targets and pathways, with particular emphasis on modulation of the gut microbiota and the neuroendocrine-immune network.
A vizsgálat 2 csoportja
- Hewei Anchang Formula GroupA vizsgált kezelés
Participants assigned to this group will receive Hewei Anchang Formula granules orally, one sachet twice daily for 4 weeks. Each dose will be dissolved in approximately 100 mL of warm water and taken 1 hour after breakfast and dinner.
Kezelés: Hewei Anchang Formula Granules
- Placebo GroupPlacebo, összehasonlításként
Participants assigned to this group will receive matching placebo granules containing 5% Hewei Anchang Formula granules, one sachet twice daily for 4 weeks. Each dose will be dissolved in approximately 100 mL of warm water and taken 1 hour after breakfast and dinner.
Kezelés: Hewei Anchang Formula Matching Placebo Granules
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT07715760: ki vehet részt
- A regiszteradat frissítve
- 2026. július 20.